Schedule 13G ownership disclosure

Jade Biosciences Inc

Common Stock, $0.0001 par value · CUSIP: 008064206

Event date: 2025-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Venrock Healthcare Capital Partners III, L.P.

    Shares: 5,115,862.00 · Class: 9.9%

  • VHCP Co-Investment Holdings III, LLC

    Shares: 5,115,862.00 · Class: 9.9%

  • Venrock Healthcare Capital Partners EG, L.P.

    Shares: 5,115,862.00 · Class: 9.9%

  • VHCP Management III, LLC

    Shares: 5,115,862.00 · Class: 9.9%

  • VHCP Management EG, LLC

    Shares: 5,115,862.00 · Class: 9.9%

  • Nimish Shah

    Shares: 5,115,862.00 · Class: 9.9%

  • Bong Y. Koh

    Shares: 5,115,862.00 · Class: 9.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001738048-26-000022
Form type
SCHEDULE 13G/A
Filer
Jade Biosciences, Inc.
CIK
CIK 1798749
Filed
Feb 17, 2026
Reporting period
Dec 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub